Cargando…
Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer
Pancreatic cancer is a malignant tumor with poor prognosis. The treatment of pancreatic cancer depends on the tumor stage and type, and includes local treatment (surgery, radiotherapy and ablation intervention) and systemic therapy (chemotherapy, targeted therapy and immunotherapy). We read with gre...
Autores principales: | Huang, Jun-Hao, Guo, Wei, Liu, Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850937/ https://www.ncbi.nlm.nih.gov/pubmed/36688025 http://dx.doi.org/10.3748/wjg.v29.i3.579 |
Ejemplares similares
-
Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer?
por: Hao, Fulong, et al.
Publicado: (2023) -
Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer
por: Zhang, Zheng, et al.
Publicado: (2021) -
WWOX rs11644322 Polymorphism, Gemcitabine, and Pancreatic Cancer
por: Yasri, Sora, et al.
Publicado: (2017) -
Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
por: Fraunhoffer, Nicolas Alejandro, et al.
Publicado: (2022) -
Tuning gut microbiota through a probiotic blend in gemcitabine‐treated pancreatic cancer xenografted mice
por: Panebianco, Concetta, et al.
Publicado: (2021)